Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Smith & Nephew stock

SN.L
GB0009223206
502816

Price

12.90
Today +/-
+0.09
Today %
+0.77 %

Smith & Nephew stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Smith & Nephew stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Smith & Nephew stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Smith & Nephew stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Smith & Nephew's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Smith & Nephew Stock Price History

DateSmith & Nephew Price
2/4/202512.90 undefined
2/3/202512.80 undefined
1/31/202512.79 undefined
1/30/202512.82 undefined
1/29/202512.73 undefined
1/28/202512.75 undefined
1/27/202512.64 undefined
1/24/202512.51 undefined
1/23/202512.46 undefined
1/22/202512.65 undefined
1/21/202512.80 undefined
1/20/202512.67 undefined
1/17/202512.48 undefined
1/16/202512.50 undefined
1/15/202512.37 undefined
1/14/202511.94 undefined
1/13/202512.03 undefined
1/10/202512.06 undefined
1/9/202512.36 undefined
1/8/202512.21 undefined
1/7/202512.31 undefined

Smith & Nephew Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Smith & Nephew, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Smith & Nephew from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Smith & Nephew’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Smith & Nephew. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Smith & Nephew’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Smith & Nephew’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Smith & Nephew’s growth potential.

Smith & Nephew Revenue, EBIT and net profit per share

DateSmith & Nephew RevenueSmith & Nephew EBITSmith & Nephew Net Income
2030e8.4 B undefined0 undefined0 undefined
2029e7.95 B undefined0 undefined0 undefined
2028e7.26 B undefined1.55 B undefined1.2 B undefined
2027e6.87 B undefined1.47 B undefined1.08 B undefined
2026e6.5 B undefined1.19 B undefined1.06 B undefined
2025e6.19 B undefined1.08 B undefined935.43 M undefined
2024e5.9 B undefined927.94 M undefined794.47 M undefined
20235.55 B undefined705 M undefined263 M undefined
20225.22 B undefined634 M undefined223 M undefined
20215.21 B undefined720 M undefined524 M undefined
20204.56 B undefined512 M undefined448 M undefined
20195.14 B undefined1.03 B undefined600 M undefined
20184.9 B undefined1.01 B undefined663 M undefined
20174.77 B undefined918 M undefined767 M undefined
20164.67 B undefined890 M undefined784 M undefined
20154.63 B undefined895 M undefined410 M undefined
20144.62 B undefined965 M undefined501 M undefined
20134.35 B undefined899 M undefined556 M undefined
20124.14 B undefined846 M undefined729 M undefined
20114.27 B undefined862 M undefined582 M undefined
20103.96 B undefined935 M undefined615 M undefined
20093.77 B undefined796 M undefined472 M undefined
20083.8 B undefined698 M undefined377 M undefined
20073.37 B undefined565 M undefined316 M undefined
20062.78 B undefined537 M undefined745 M undefined
20052.56 B undefined516.2 M undefined339.9 M undefined
20042.29 B undefined423.1 M undefined229.3 M undefined

Smith & Nephew Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (B)DOCUMENTS
19931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e2030e
1.421.481.621.671.721.751.811.721.561.671.932.292.562.783.373.83.773.964.274.144.354.624.634.674.774.95.144.565.215.225.555.96.196.56.877.267.958.4
-3.659.693.092.881.693.72-5.19-9.326.9415.6218.8111.818.6821.2312.82-0.765.047.77-3.115.176.110.370.762.062.924.77-11.2514.300.066.406.244.925.085.745.689.535.63
55.0654.1354.9156.0857.4357.2757.1059.7067.6370.2770.7573.1574.3472.3370.5071.6772.6973.9873.3074.1475.1175.5975.3372.7673.8173.6174.1969.8571.0970.9770.1966.0762.9759.9356.6853.6448.9746.36
0.780.80.890.940.9911.031.031.051.171.361.671.92.012.382.722.742.933.133.073.273.493.493.43.523.613.813.193.713.73.90000000
0.16-0.080.180.190.190.160.170.310.190.170.240.230.340.750.320.380.470.620.580.730.560.50.410.780.770.660.60.450.520.220.260.790.941.061.081.200
--150.93-317.075.62-1.60-16.228.3985.12-40.19-9.6843.45-4.9848.03119.76-57.5819.3025.2030.30-5.3725.26-23.73-9.89-18.1691.22-2.17-13.56-9.50-25.3316.96-57.4417.94201.9017.7612.942.3711.38--
--------------------------------------
--------------------------------------
1.031.091.11.111.111.121.121.040.930.930.940.940.940.940.930.890.890.890.90.90.910.90.90.890.880.880.880.880.880.870.870000000
--------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Smith & Nephew Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Smith & Nephew is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (M)INVENTORIES (B)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (B)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (B)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
1993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                             
0.280.210.060.140.090.080.160.040.040.070.050.060.150.350.170.150.190.210.180.180.140.090.120.10.170.370.281.761.290.350.3
0.320.350.38000000.340.360.440.530.560.570.760.790.80.880.90.920.940.970.940.991.061.11.080.910.971.031.06
000000003.23.72.62.30567473715550656051837692107145195201151155
0.290.310.340.390.370.40.390.340.340.370.410.550.610.620.840.880.930.920.860.91.011.181.221.241.31.41.611.691.842.212.4
46.456.7610000042.551151164.274566510077888785118147116121110106101105118123119
0.930.920.840.530.470.480.550.380.760.861.061.31.391.651.911.992.072.152.082.142.262.442.482.532.733.083.224.664.423.864.03
0.360.380.410.440.460.480.440.380.360.410.460.540.590.640.740.730.750.790.780.790.820.890.930.981.051.061.321.451.511.461.47
8.34.921.71.623.227.535.9203.1212.2226241.5228.91020192019171181091171281371391391101171985824
0000000000000000022016717800000002011510
0.010.010.020.030.030.050.120.240.040.060.050.060.090.190.450.380.410.430.421.061.051.751.51.411.371.211.571.491.41.241.11
000000000.230.460.430.580.580.641.21.191.091.11.11.191.262.032.012.192.372.342.792.932.993.032.99
000000000000130.81101352142162243481701508411897205234291368398330361
0.370.40.430.470.50.550.590.660.831.141.171.421.621.592.552.522.492.582.673.53.564.874.694.825.144.986.086.356.76.265.96
1.31.321.281.010.961.041.131.041.61.992.222.723.023.234.454.514.574.734.755.645.827.317.177.347.878.069.311.0111.1210.129.99
                                                             
152.9171.4171.3190182.8183.6181.2167.5164.9183.3203.7219.7197.9189190190190191191193184184183180178177177177177175175
42.5145.8160.1184.9184.5188.5190.9187197.5231.7271.4306.2292.6329356375382396413488535574590600605608610612614615615
0.320.380.30.370.390.430.520.140.230.420.670.8811.661.911.962.42.963.353.943.653.63.493.614.124.34.544.654.94.594.52
0000000000000000000000000000-328-4390
0000000000000000000000000000000
0.510.70.630.750.760.80.890.490.590.831.151.41.492.182.452.522.973.553.954.624.374.364.264.394.95.095.335.445.364.945.31
0.140.150.180.430.440.480.50.480.220.230.240.30.30.40.510.540.550.580.550.650.750.810.810.810.870.850.940.891.041.031.02
66.780.586.60000086.2104.9118.4124.5127.4000000000000000000
200.5120.611700000159.5154189.1301359.7299321309271273264246278316490455446447551460597526490
00000000000000000000112818621432201156305
0.290.180.170.190.150.140.090.120.160.250.170.060.230.121.440.120.050.060.310.040.030.010.030.020.010.130.050.330.490.150.46
0.70.520.550.620.590.620.60.60.620.740.720.791.010.822.270.970.860.911.120.931.071.161.341.351.351.471.561.692.131.722.27
0.040.030.020.020.020.020.030.270.240.260.180.280.210.020.041.361.090.640.020.430.351.671.431.561.421.31.983.352.852.712.32
1.9000000080.690.2110.561.653.435634631696661509877949799167141144369
47.474.579.554.851.151.366.386.867.561.966.2204.7254.7191264437402335359337302340346380356320452551229244171
0.090.10.10.080.080.070.10.350.390.420.350.540.520.240.361.841.521.050.440.830.72.11.862.041.881.722.594.053.222.992.5
0.790.630.650.70.660.690.70.961.011.161.081.331.531.062.632.812.391.961.561.761.773.273.23.393.223.194.165.735.354.714.77
1.31.321.281.441.421.51.591.451.61.992.232.733.023.235.095.335.365.515.516.386.147.627.467.788.128.279.4911.1710.719.6510.08
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Smith & Nephew provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Smith & Nephew's financial health and stability.

Assets

Smith & Nephew's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Smith & Nephew must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Smith & Nephew after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Smith & Nephew's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
1993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0.250.220.27000.230.190.250.220.230.290.280.430.550.470.560.670.90.851.10.80.710.561.060.880.780.740.250.590.240.29
545662676782909586111127155179166228275298273297312361427493463447427502562567617683
0000000000000000000000000000000
-168-118-138159155-59-69-81-164-147-165-82-359-351-385-389-319-360-350-306-345-517-123-356-285-366-17524-321-648-553
-1636-2700-1819-30-1361430167126116705147-2044959101-32049899810345264188
8525181521161116272524171894068432012810364448505456618073104
78701126268349771109788569112144225186270235285278265245137141135125150-229747125
0.110.190.160.230.220.230.230.230.140.230.270.380.270.370.440.570.720.860.840.90.870.681.030.851.090.931.170.940.880.470.61
-99-97-110-113-118-114-108-96-107-127-119-186-201-231-200-292-318-315-321-265-340-375-358-392-376-347-408-443-408-358-427
-30-65-214-176-116-125-106248-97-322-38-249-199232-975-305-206-307-354-954-407-1,745-429-383-543-378-1,251-606-691-472-448
6831-103-621-11134410-19481-621463-775-131128-33-689-67-1,370-719-167-31-843-163-283-114-21
0000000000000000000000000000000
-0.15-0.06-0.050.050-0.02-0.030.240.030.13-0.16-0.110.03-0.291.080.03-0.35-0.42-0.390.16-0.081.3-0.220.13-0.15-0.010.381.49-0.33-0.450.12
28107177656121391172016-612-17017181883-180-31-56-352-42-35-52-514-1520
-0.19-0.03-0.13-0.03-0.1-0.11-0.15-0.48-0.030.08-0.23-0.12-0.04-0.380.35-0.24-0.47-0.54-0.520.05-0.51.01-0.56-0.53-0.43-0.370.011.16-0.65-0.93-0.2
0000011-11-15-200072-3-10-145-12-3-1-1-1-11-15-2524-8-27-434
-70-79-90-93-109-114-113-720-60-65-73-85-90-96-105-109-120-132-146-186-239-250-272-279-269-321-318-328-329-327-327
-0.110.1-0.180.020.01-0.01-0.02-00.01-0.020.010.010.030.23-0.180.010.050.02-0.030.01-0.04-0.060.04-0.060.120.18-0.081.49-0.47-0.94-0.04
15.696.954.2112.4104.8116119.7131.635.398.3150.4192.965.5141238274401544521637527308672457714584760492469110181
0000000000000000000000000000000

Smith & Nephew stock margins

The Smith & Nephew margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Smith & Nephew. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Smith & Nephew.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Smith & Nephew's sales revenue. A higher gross margin percentage indicates that the Smith & Nephew retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Smith & Nephew's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Smith & Nephew's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Smith & Nephew's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Smith & Nephew. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Smith & Nephew's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Smith & Nephew Margin History

Smith & Nephew Gross marginSmith & Nephew Profit marginSmith & Nephew EBIT marginSmith & Nephew Profit margin
2030e70.19 %0 %0 %
2029e70.19 %0 %0 %
2028e70.19 %21.29 %16.59 %
2027e70.19 %21.43 %15.74 %
2026e70.19 %18.31 %16.25 %
2025e70.19 %17.48 %15.12 %
2024e70.19 %15.74 %13.48 %
202370.19 %12.7 %4.74 %
202270.97 %12.16 %4.28 %
202171.09 %13.81 %10.05 %
202069.85 %11.23 %9.82 %
201974.19 %19.97 %11.68 %
201873.61 %20.6 %13.52 %
201773.81 %19.27 %16.1 %
201672.76 %19.06 %16.79 %
201575.33 %19.31 %8.85 %
201475.59 %20.9 %10.85 %
201375.11 %20.66 %12.78 %
201274.14 %20.45 %17.62 %
201173.3 %20.19 %13.63 %
201073.98 %23.6 %15.52 %
200972.69 %21.1 %12.51 %
200871.67 %18.36 %9.92 %
200770.5 %16.77 %9.38 %
200672.33 %19.32 %26.81 %
200574.34 %20.19 %13.29 %
200473.18 %18.5 %10.03 %

Smith & Nephew Stock Sales Revenue, EBIT, Earnings per Share

The Smith & Nephew earnings per share therefore indicates how much revenue Smith & Nephew has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Smith & Nephew earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Smith & Nephew's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Smith & Nephew’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Smith & Nephew's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Smith & Nephew Revenue, EBIT and net profit per share

DateSmith & Nephew Sales per ShareSmith & Nephew EBIT per shareSmith & Nephew Earnings per Share
2030e9.61 undefined0 undefined0 undefined
2029e9.1 undefined0 undefined0 undefined
2028e8.31 undefined0 undefined1.38 undefined
2027e7.86 undefined0 undefined1.24 undefined
2026e7.43 undefined0 undefined1.21 undefined
2025e7.07 undefined0 undefined1.07 undefined
2024e6.74 undefined0 undefined0.91 undefined
20236.36 undefined0.81 undefined0.3 undefined
20225.96 undefined0.72 undefined0.26 undefined
20215.94 undefined0.82 undefined0.6 undefined
20205.2 undefined0.58 undefined0.51 undefined
20195.86 undefined1.17 undefined0.68 undefined
20185.6 undefined1.15 undefined0.76 undefined
20175.45 undefined1.05 undefined0.88 undefined
20165.23 undefined1 undefined0.88 undefined
20155.15 undefined1 undefined0.46 undefined
20145.14 undefined1.07 undefined0.56 undefined
20134.8 undefined0.99 undefined0.61 undefined
20124.59 undefined0.94 undefined0.81 undefined
20114.77 undefined0.96 undefined0.65 undefined
20104.46 undefined1.05 undefined0.69 undefined
20094.26 undefined0.9 undefined0.53 undefined
20084.27 undefined0.78 undefined0.42 undefined
20073.63 undefined0.61 undefined0.34 undefined
20062.94 undefined0.57 undefined0.79 undefined
20052.71 undefined0.55 undefined0.36 undefined
20042.43 undefined0.45 undefined0.24 undefined

Smith & Nephew business model

Smith & Nephew PLC was founded in 1856 by Thomas James Smith in Hull, United Kingdom, as a manufacturer of bandages and orthopedic products. The company has since evolved into a globally operating healthcare company specializing in the manufacturing and distribution of medical devices. The company is divided into three business segments: Orthopaedics, Endoscopy, and Advanced Wound Management. The product range includes a wide range of products used for the treatment of injuries and diseases. This includes artificial joints, instruments for minimally invasive surgery, as well as wound care products such as dressings, compression stockings, and pain therapy systems. The Orthopaedics business segment offers a wide range of products for the treatment of arthritis, joint injuries, and other orthopedic conditions. This includes artificial joints, knee and hip prostheses, and implants for bone fracture stabilization. The company was one of the first to develop an artificial joint prosthesis and has since played a leading role in this field. The Endoscopy business segment provides instruments for minimally invasive surgery. These devices allow surgeons to perform less invasive surgical procedures that allow for faster patient recovery. The product range includes endoscopes, probes, and other instruments used for surgeries in the abdominal cavity, thoracic cavity, joints, and other areas of the body. Smith & Nephew's Advanced Wound Management business segment offers products for effective wound treatment. This includes wound dressings, compression stockings, shoes, and pain therapy systems. These products help reduce healing time and decrease the likelihood of infections. Smith & Nephew is headquartered in London, United Kingdom, and employs over 17,500 people worldwide. The company operates in more than 100 countries and has manufacturing facilities in Europe, Asia, and North America. In 2020, Smith & Nephew's revenue amounted to $4.6 billion. The business model of Smith & Nephew is based on innovation and the development of new technologies. The company invests a significant portion of its revenue each year in research and development to expand and improve its product range. Additionally, the company works closely with doctors and hospitals to better understand patient needs and offer tailored solutions. In recent years, Smith & Nephew has also invested in digital health. The company utilizes innovative technologies such as artificial intelligence and cloud solutions to provide better care and support to patients. This includes the introduction of mobile apps that assist patients in monitoring and self-treating their conditions. In conclusion, Smith & Nephew is a globally operating healthcare company specializing in the manufacturing and distribution of medical devices. The company has a wide product range used for the treatment of injuries and diseases. Its business model is based on innovation and the development of new technologies. Close collaboration with doctors and hospitals, as well as the utilization of digital technologies, are important pillars of the company. Smith & Nephew is one of the most popular companies on Eulerpool.com.

Smith & Nephew SWOT Analysis

Strengths

Smith & Nephew PLC has a strong brand reputation in the healthcare industry.

Being a global company, Smith & Nephew has a widespread distribution network.

The company has a diverse product portfolio offering various innovative medical devices.

Smith & Nephew has a strong research and development capability, allowing it to constantly introduce new products and stay ahead of competitors.

The company has a highly skilled and experienced workforce.

Weaknesses

Smith & Nephew may face challenges in effectively managing its global operations due to geographical and cultural differences.

The company's reliance on external suppliers for raw materials may lead to supply chain vulnerabilities.

Smith & Nephew's pricing strategy may not always be competitive compared to other players in the industry.

The company may encounter regulatory barriers and compliance challenges in different markets.

Smith & Nephew's dependency on a few key markets for a significant portion of its revenue exposes it to market risks.

Opportunities

The increasing global healthcare expenditure provides an opportunity for Smith & Nephew to expand its market presence and generate higher revenue.

Advancements in medical technology present opportunities for the company to develop and launch new innovative products.

Entering emerging markets with rising healthcare demands can open up new growth prospects for Smith & Nephew.

The aging population in many countries creates a growing market for joint replacement surgeries and other medical interventions offered by the company.

Healthcare policies and regulations promoting the use of medical devices can drive the demand for Smith & Nephew's products.

Threats

The intense competition in the healthcare industry poses threats to Smith & Nephew's market share and profitability.

Fluctuating raw material prices can impact the company's manufacturing costs and profit margins.

Economic downturns and financial uncertainties in key markets may affect the demand for expensive medical devices.

Stringent regulations and compliance requirements can disrupt the company's operations and increase costs.

Technological advancements by competitors may undermine Smith & Nephew's competitive advantage.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Smith & Nephew Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Smith & Nephew historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Smith & Nephew shares outstanding

The number of shares was Smith & Nephew in 2024 — This indicates how many shares 873 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Smith & Nephew earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Smith & Nephew's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Smith & Nephew’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Smith & Nephew's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Smith & Nephew stock splits

In Smith & Nephew's history, there have been no stock splits.

Smith & Nephew dividend history and estimates

In 2024, Smith & Nephew paid a dividend amounting to 0.53 USD. Dividend means that Smith & Nephew distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Smith & Nephew provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Smith & Nephew’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Smith & Nephew's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Smith & Nephew Dividend History

DateSmith & Nephew Dividend
2030e0.3 undefined
2029e0.3 undefined
2028e0.3 undefined
2027e0.3 undefined
2026e0.3 undefined
2025e0.3 undefined
2024e0.31 undefined
20230.3 undefined
20220.31 undefined
20210.27 undefined
20200.3 undefined
20190.28 undefined
20180.27 undefined
20170.24 undefined
20160.23 undefined
20150.22 undefined
20140.19 undefined
20130.25 undefined
20120.23 undefined
20110.14 undefined
20100.11 undefined
20090.15 undefined
20080.14 undefined
20070.12 undefined
20060.11 undefined
20050.06 undefined
20040.06 undefined

Smith & Nephew dividend payout ratio

In 2024, Smith & Nephew had a payout ratio of 81.23%. The payout ratio indicates the percentage of the company's profits that Smith & Nephew distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Smith & Nephew represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Smith & Nephew could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Smith & Nephew's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Smith & Nephew Payout Ratio History

DateSmith & Nephew Payout ratio
2030e86.3 %
2029e85.55 %
2028e87.45 %
2027e85.9 %
2026e83.29 %
2025e93.16 %
2024e81.23 %
202375.48 %
2022122.78 %
202145.44 %
202058.2 %
201941.19 %
201835.56 %
201727.31 %
201626.29 %
201548.78 %
201433.75 %
201341.33 %
201228.4 %
201121.5 %
201015.55 %
200928.47 %
200832.65 %
200736.67 %
200614.53 %
200516.36 %
200423.13 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Smith & Nephew.

Smith & Nephew latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/20140.26 0.26  (0.54 %)2014 Q4
9/30/20140.2 0.2  (-1.22 %)2014 Q3
6/30/20140.2 0.2  (3.98 %)2014 Q2
3/31/20140.19 0.18  (-4.94 %)2014 Q1
12/31/20130.23 0.23  (0.91 %)2013 Q4
9/30/20130.17 0.17  (-2.3 %)2013 Q3
6/30/20130.19 0.18  (-3.45 %)2013 Q2
3/31/20130.19 0.18  (-2.18 %)2013 Q1
12/31/20120.21 0.22  (1.03 %)2012 Q4
9/30/20120.17 0.17  (-2.12 %)2012 Q3
1
2
3
4
...
5

Eulerpool ESG Scorecard© for the Smith & Nephew stock

Eulerpool World ESG Rating (EESG©)

84/ 100

🌱 Environment

67

👫 Social

99

🏛️ Governance

86

Environment

Scope 1 - Direct Emissions
12,168
Scope 2 - Indirect emissions from purchased energy
61,817
Scope 3 - Indirect emissions within the value chain
1,385,356
Total CO₂ emissions
73,985
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees43
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Smith & Nephew shareholders

%
Name
Stocks
Change
Date
5.30971 % BlackRock Institutional Trust Company, N.A.46,427,00002/16/2024
5.02088 % Cevian Capital43,901,52743,901,5277/2/2024
3.05390 % Norges Bank Investment Management (NBIM)26,702,6861,567,0566/28/2024
2.84781 % The Vanguard Group, Inc.24,900,689469,7647/29/2024
2.19477 % Harris Associates L.P.19,190,600010/1/2024
2.04964 % T. Rowe Price Associates, Inc.17,921,647-1,434,4107/25/2024
1.89780 % Columbia Threadneedle Investments (UK)16,593,960010/1/2024
1.55869 % Sprucegrove Investment Management, Ltd.13,628,89385,9308/1/2024
1.35444 % Jupiter Asset Management Ltd.11,842,950-87,6488/1/2024
1.31741 % Amundi Ireland Limited11,519,1691,889,5398/31/2024
1
2
3
4
5
...
10

Smith & Nephew Executives and Management Board

Mr. Deepak Nath

Smith & Nephew Chief Executive Officer, Executive Director (since 2022)
Compensation 5.96 M

Ms. Anne-Francoise Nesmes

(52)
Smith & Nephew Chief Financial Officer, Executive Director (since 2020)
Compensation 1.35 M

Mr. Marc Owen

Smith & Nephew Senior Non-Executive Independent Director
Compensation 185,780

Mr. John Ma

(60)
Smith & Nephew Non-Executive Independent Director
Compensation 150,780

Mr. Bob White

(60)
Smith & Nephew Non-Executive Independent Director
Compensation 136,780
1
2
3
4
...
5

Most common questions regarding Smith & Nephew

What values and corporate philosophy does Smith & Nephew represent?

Smith & Nephew PLC represents a strong commitment to providing innovative medical solutions and advanced healthcare technology. The company values include a focus on patient-centered care, continuous improvement, integrity, and collaboration. Smith & Nephew is dedicated to improving the quality of life for patients around the world through their range of products and services. They prioritize delivering superior outcomes for patients, healthcare professionals, and stakeholders. The corporate philosophy of Smith & Nephew revolves around driving sustainable growth, embracing diversity and inclusion, and maintaining their position as a global leader in medical technology.

In which countries and regions is Smith & Nephew primarily present?

Smith & Nephew PLC is primarily present in various countries and regions worldwide. The company has a global presence and operates in key markets such as the United States, the United Kingdom, Europe, Asia Pacific, and the Middle East. It has a wide reach and serves patients and healthcare professionals in many countries, including the United States, Canada, Germany, France, China, Japan, Australia, and the United Arab Emirates. With its extensive international presence, Smith & Nephew PLC is able to provide innovative medical solutions and services to customers across different regions and deliver quality healthcare products to a diverse range of patients worldwide.

What significant milestones has the company Smith & Nephew achieved?

Smith & Nephew PLC, a leading medical technology company, has achieved several significant milestones throughout its history. Since its inception, the company has been at the forefront of innovation, revolutionizing the healthcare industry. Smith & Nephew expanded its global presence and experienced substantial growth, establishing a strong reputation for excellence. The company's achievements include the development of groundbreaking products and solutions, successful acquisitions and partnerships, and recognition for its commitment to patient care. Smith & Nephew PLC continues to make remarkable strides, driving advancements in medical technology and making a positive impact in the lives of patients worldwide.

What is the history and background of the company Smith & Nephew?

Smith & Nephew PLC is a renowned medical technology company with a rich history and background. Founded in 1856, the company has evolved into a global leader in advanced healthcare solutions. Smith & Nephew specializes in developing innovative products and medical devices across various segments, including orthopedics, sports medicine, and advanced wound management. With a strong commitment to improving patient outcomes, the company's cutting-edge technology and dedication to research have led to significant advancements in surgical procedures and wound care management. Smith & Nephew PLC's long-standing history of excellence and continuous innovation position it as a trusted name in the medical industry.

Who are the main competitors of Smith & Nephew in the market?

The main competitors of Smith & Nephew PLC in the market include Medtronic PLC, Stryker Corporation, and Johnson & Johnson.

In which industries is Smith & Nephew primarily active?

Smith & Nephew PLC is primarily active in the medical device industry.

What is the business model of Smith & Nephew?

The business model of Smith & Nephew PLC is focused on providing innovative medical devices and advanced technology solutions to improve patient outcomes and enhance healthcare efficiency. As a leading global medical technology company, Smith & Nephew specializes in the areas of orthopedics, sports medicine, and advanced wound management. Combining research, development, manufacturing, and marketing capabilities, the company aims to address unmet medical needs and deliver high-quality products and services to healthcare professionals and patients worldwide. Smith & Nephew PLC strives to continuously innovate and collaborate with healthcare stakeholders to make a meaningful difference in the field of medical technology.

What is the P/E ratio of Smith & Nephew 2025?

The Smith & Nephew P/E ratio is 12.04.

What is the P/S ratio of Smith & Nephew 2025?

The Smith & Nephew P/S ratio is 1.82.

What is the Quality Investing of Smith & Nephew?

The Quality Investing for Smith & Nephew is 5/10.

What is the revenue of Smith & Nephew 2025?

The expected Smith & Nephew revenue is 6.19 B USD.

How high is the profit of Smith & Nephew 2025?

The expected Smith & Nephew profit is 935.43 M USD.

What is the business model of Smith & Nephew

Smith & Nephew PLC is a global company specializing in medical technology. The company offers a wide range of products and solutions for orthopedics, sports medicine, biologics, and wound care. The orthopedics division of Smith & Nephew manufactures innovative products for the treatment of joint problems. This includes implants for hip, knee, shoulder, elbow, and hand joints, which are developed and produced by the company itself. In addition, Smith & Nephew also offers instruments that are used during surgeries. The sports medicine division of Smith & Nephew specializes in developing solutions for the treatment of sports injuries. This includes arthroscopy cameras, products for repairing synovial tissue, and other instruments that allow doctors to diagnose and treat injuries. The biologics division of Smith & Nephew produces products that focus on tissue regeneration. This includes biodegradable polymers, growth factors, and synthetic bone substitutes. These products can help support the natural healing of bones and tissues and can be used in various medical fields. The wound care division of Smith & Nephew produces a wide range of products that can be used for wound care in patients. This includes dressings, wound dressings, and antiseptics. An important factor of Smith & Nephew's business model is the company's global expansion. The company is present in over 100 countries and continuously works to expand its presence on a global level. This allows the company to sell its products on a broader scale and increase its market share. Another important factor of Smith & Nephew's business model is its focus on research and development. The company invests a significant portion of its operating profit in research and development to develop innovative products and improve existing solutions. This allows the company to offer cutting-edge technologies to its customers worldwide and increase its competitiveness in the market. Overall, Smith & Nephew's business model is focused on delivering innovative solutions for the medical care of patients. The company relies on a wide range of products, international expansion, and high investments in research and development to offer our customers worldwide high-quality products and services.

What is the Smith & Nephew dividend?

Smith & Nephew pays a dividend of 0.31 USD distributed over 2 payouts per year.

How often does Smith & Nephew pay dividends?

Smith & Nephew pays out a dividend 2 times a year.

What is the Smith & Nephew ISIN?

The ISIN of Smith & Nephew is GB0009223206.

What is the Smith & Nephew WKN?

The WKN of Smith & Nephew is 502816.

What is the Smith & Nephew ticker?

The ticker of Smith & Nephew is SN.L.

How much dividend does Smith & Nephew pay?

Over the past 12 months, Smith & Nephew paid a dividend of 0.3 USD . This corresponds to a dividend yield of about 2.35 %. For the coming 12 months, Smith & Nephew is expected to pay a dividend of 0.3 USD.

What is the dividend yield of Smith & Nephew?

The current dividend yield of Smith & Nephew is 2.35 %.

When does Smith & Nephew pay dividends?

Smith & Nephew pays a quarterly dividend. This is distributed in the months of November, April, May, November.

How secure is the dividend of Smith & Nephew?

Smith & Nephew paid dividends every year for the past 0 years.

What is the dividend of Smith & Nephew?

For the upcoming 12 months, dividends amounting to 0.3 USD are expected. This corresponds to a dividend yield of 2.36 %.

In which sector is Smith & Nephew located?

Smith & Nephew is assigned to the 'Health' sector.

Wann musste ich die Aktien von Smith & Nephew kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Smith & Nephew from 11/8/2024 amounting to 0.111 USD, you needed to have the stock in your portfolio before the ex-date on 10/3/2024.

When did Smith & Nephew pay the last dividend?

The last dividend was paid out on 11/8/2024.

What was the dividend of Smith & Nephew in the year 2024?

In the year 2024, Smith & Nephew distributed 0.303 USD as dividends.

In which currency does Smith & Nephew pay out the dividend?

The dividends of Smith & Nephew are distributed in USD.

All fundamentals about Smith & Nephew

Our stock analysis for Smith & Nephew Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Smith & Nephew Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.